119 related articles for article (PubMed ID: 2431021)
1. Theophylline reduces histamine release during pollen-induced rhinitis.
Naclerio RM; Bartenfelder D; Proud D; Togias AG; Meyers DA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 1):874-6. PubMed ID: 2431021
[TBL] [Abstract][Full Text] [Related]
2. Theophylline reduces the response to nasal challenge with antigen.
Naclerio RM; Bartenfelder D; Proud D; Togias AG; Meyers DA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
Am J Med; 1985 Dec; 79(6A):43-7. PubMed ID: 2417477
[TBL] [Abstract][Full Text] [Related]
3. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
[TBL] [Abstract][Full Text] [Related]
5. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
Pipkorn U; Proud D; Lichtenstein LM; Kagey-Sobotka A; Norman PS; Naclerio RM
N Engl J Med; 1987 Jun; 316(24):1506-10. PubMed ID: 2438553
[TBL] [Abstract][Full Text] [Related]
7. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen.
Majchel AM; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Clin Exp Allergy; 1990 Nov; 20(6):701-5. PubMed ID: 1707333
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory mediators in late antigen-induced rhinitis.
Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
[TBL] [Abstract][Full Text] [Related]
9. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen.
Proud D; Naclerio RM; Meyers DA; Kagey-Sobotka A; Lichtenstein LM; Valentine MD
Int Arch Allergy Appl Immunol; 1990; 93(2-3):165-70. PubMed ID: 1965981
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of the discontinuation of ragweed immunotherapy.
Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
[TBL] [Abstract][Full Text] [Related]
11. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
[TBL] [Abstract][Full Text] [Related]
12. The effect of cetirizine on early allergic response.
Naclerio RM; Proud D; Kagey-Sobotka A; Freidhoff L; Norman PS; Lichtenstein LM
Laryngoscope; 1989 Jun; 99(6 Pt 1):596-9. PubMed ID: 2566879
[TBL] [Abstract][Full Text] [Related]
13. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air.
Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):761-5. PubMed ID: 1706910
[TBL] [Abstract][Full Text] [Related]
14. Mediator release after allergic and physical nasal challenges.
Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
[TBL] [Abstract][Full Text] [Related]
15. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis.
Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S
Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852
[TBL] [Abstract][Full Text] [Related]
16. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
Chung JH; deTineo ML; Naclerio RM; Sorrentino JV; Winslow CM; Baroody FM
Ann Allergy Asthma Immunol; 1997 Mar; 78(3):307-12. PubMed ID: 9087158
[TBL] [Abstract][Full Text] [Related]
17. The effect of azelastine on the early allergic response.
Shin MH; Baroody F; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Clin Exp Allergy; 1992 Feb; 22(2):289-95. PubMed ID: 1349259
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mediator release during the early reaction to antigen.
Naclerio RM
J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 2):715-9. PubMed ID: 1401653
[TBL] [Abstract][Full Text] [Related]
19. Localized antigen challenge of the nasal mucosa.
Flowers BK; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1407-10. PubMed ID: 2248741
[TBL] [Abstract][Full Text] [Related]
20. Substance P enhances antigen-evoked mediator release from human nasal mucosa.
Baumgarten CR; Witzel A; Kleine-Tebbe J; Kunkel G
Peptides; 1996; 17(1):25-30. PubMed ID: 8822506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
